NASDAQ-listed Lumenis provides energy-based, minimally invasive clinical solutions for the surgical, ophthalmology and aesthetic markets. (Its locations include Yokneam, Israel, where surgical and aesthetic products are manufactured, and Salt Lake City, Utah, where ophthalmic products are manufactured). XIO Group is a Hong Kong based alternative investments firm with over $ 3 billion in capital.
XIO Group is listed in the Chinese Private Equity and Venture Capital Directory with the code XJU44
More details follows
Previous Post: Chinese investors of Hua Capital and consortium acquired OmniVision for $1.9 billion
Next Post: Chinese firm invested $12 million in UK oil and gas technology firm Plexus